On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
66° Feels Like: 66°
Wind: N 7 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Scattered Thunderstorms 53°

Tomorrow

AM Showers 59°

Mon Night

Clear 39°

Alerts

Bayer says Nexavar fails in breast cancer study

FRANKFURT (Reuters) - German drugmaker Bayer said a Phase III trial of cancer drug Nexavar in patients with advanced breast cancer did not meet its primary endpoint of delaying the progression of the disease.

The study, called Resilience, evaluated Nexavar in combination with chemotherapeutic agent capecitabine, in women with HER2-negative breast cancer.

Oral drug Nexavar, which Bayer is developing jointly with Amgen, is approved for use against certain types of liver, kidney and thyroid cancer.

Study details are expected to be presented at an upcoming scientific conference.

(Reporting by Ludwig Burger; Editing by Kirsti Knolle)

Comments